Medical Properties Trust, Inc. (NYSE: MPT) Stock Analysis & Fundamentals

MPTMedical Properties Trust, Inc.

NYSE · US · Real Estate · REIT - Healthcare Facilities · medicalpropertiestrust.com

4.620USD0.00%Mkt Cap: 2.76B $P/E: —1d ago

Medical Properties Trust, Inc. is a self-advised real estate investment trust to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the w…

Industry Peers

REIT - Healthcare Facilities

Screen all

vs REIT - Healthcare Facilities

P/B

Cheaper

Div Yield

Lower

1M Perf

Higher

Omega Healthcare Investors, Inc.

$14.87BUSDP/E 23.0

DOC

Healthpeak Properties, Inc.

Healthcare Realty Trust Incorporated

Chartwell Retirement Residences

$5.30BUSDP/E Infinity

SBRA

Sabra Health Care REIT, Inc.

$4.92BUSDP/E 31.0

NHI

National Health Investors, Inc.

Primary Health Properties Plc

$2.70BUSDP/E 13.7

DHC

Diversified Healthcare Trust

Sila Realty Trust, Inc.

$1.68BUSDP/E 44.6

NHP

National Healthcare Properties, Inc.

$1.08BUSD

CPINV

Care Property Invest NV

$578.96MUSDP/E 8.3

UHT

Universal Health Realty Income Trust

$608.58MUSDP/E 34.3

CHCT

Community Healthcare Trust Incorporated

$522.29MUSDP/E 152.3

XRN

Chiron Real Estate Inc.

$496.57MUSD

STRW

Strawberry Fields REIT, Inc.

$184.62MUSDP/E 21.5

Indicators:|

Key Statistics

Company

Market Cap2.76B $

Enterprise Value12.00B $

Revenue (TTM)1.10B $

Gross Profit935.61M $

Net Income (TTM)-277.05M $

Revenue/Share1.833 USD

Last Price4.620 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees121

CountryUS

SectorReal Estate

IndustryREIT - Healthcare Facilities

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)31.50

PEG1.61

EV/EBITDA12.63

EV/Revenue10.91

P/S2.51

P/B0.61

EPS (TTM)-0.21

EPS (Forward)0.15

52W Range

3.95027% of range6.470

52W High6.470 USD

52W Low3.950 USD

Profitability

Gross Margin96.25%

Oper. Margin58.23%

EBITDA Margin86.38%

Profit Margin-28.50%

ROE-6.01%

ROA-1.85%

Growth

Revenue Growth12.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF230.77M $

CapEx (TTM)—

FCF Margin71.11%

FCF Yield28.30%

Net Debt9.24B $

Net Debt/EBITDA9.72

Balance Sheet

Debt/Equity2.13

Current Ratio1.18

Quick Ratio1.03

Book Value/Sh7.603 USD

Cash/Share0.7110 USD

Dividends

Fwd Div Rate0.3600 USD

Trail. Div Rate0.3400 USD

Div. Yield7.79%

5Y Avg Yield10.13%

Payout Ratio1054.55%

Ex-Div DateJun 18, 2026

Pay DateJul 16, 2026

Analyst Consensus

Rating3.1 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)5.714 USD

Upside (mean)+23.7%

Target Range4.500 USD – 8.000 USD

$4.500+23.7% to mean$8.000

# Analysts7

Ownership

Shares Out.598.10M

Float490.69M

Insiders17.55%

Institutions59.49%

Short Interest

Short Ratio25.7d

Short % Float29.43%

Short % Out.22.00%

Shares Short131.57M

Short (prev mo.)132.95M

Technical

SMA 504.988 (-7.4%)

SMA 2005.115 (-9.7%)

Beta1.46

S&P 52W Chg20.05%

Avg Vol (30d)5.09M

Avg Vol (10d)8.32M

Technical Indicators

RSI (14)41.7

MACD-0.1390

MACD Signal-0.1233

MACD Hist.-0.0156

BB Upper5.233 USD

BB Middle4.769 USD

BB Lower4.306 USD

BB Width19.43%

ATR (14)0.1466 USD

Vol Ratio (20d)0.81x